The commericalization/development deal covers up to six anti-cancer assets, and gives OncoMed a 50/50 US partnership over the experimental monoclonal antibody demcizumab.
Monday’s announcement builds on a stream of recent R&D relationships.
Business briefs: Healthcare reform, Amgen, Pakistan pharma stance, digital marketing
September 25, 2013
5:01 pm
Despite a possible government standoff, exchanges are coming, as is a proffered rebrand; Amgen signs a university deal in China; Pakistan seeks to rein in pharma; digital marketing is on the rise, research shows
Business briefs: AbbVie, FDA, and health spending projections
September 24, 2013
3:10 pm
AbbVie and Galapagos go after cystic fibrosis; FDA’s NME approval pace slows; government shutdown could slow ad-com votes; and a report shows privately insured patients had emptier pockets in 2012 than 2011